Stock Analysis on Net
Stock Analysis on Net
Microsoft Excel LibreOffice Calc

Bristol-Myers Squibb Co. (NYSE:BMY)

Analysis of Liquidity Ratios

Beginner level

Liquidity Ratios (Summary)

Bristol-Myers Squibb Co., liquidity ratios

Microsoft Excel LibreOffice Calc
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Current ratio 1.60 1.61 1.55 1.55 1.30
Quick ratio 1.26 1.37 1.30 1.27 1.05
Cash ratio 0.84 0.83 0.71 0.72 0.53

Based on: 10-K (filing date: 2020-02-24), 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12).

Liquidity ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Bristol-Myers Squibb Co.’s current ratio improved from 2017 to 2018 but then slightly deteriorated from 2018 to 2019.
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Bristol-Myers Squibb Co.’s quick ratio improved from 2017 to 2018 but then deteriorated significantly from 2018 to 2019.
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Bristol-Myers Squibb Co.’s cash ratio improved from 2017 to 2018 and from 2018 to 2019.

Current Ratio

Bristol-Myers Squibb Co., current ratio calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Selected Financial Data (US$ in millions)
Current assets 29,354  17,160  14,854  13,704  10,415 
Current liabilities 18,304  10,654  9,563  8,841  8,017 
Liquidity Ratio
Current ratio1 1.60 1.61 1.55 1.55 1.30
Benchmarks
Current Ratio, Competitors2
Abbott Laboratories 1.44 1.62 2.26 4.02 1.54
AbbVie Inc. 3.18 0.98 1.28 1.65 1.50
Amgen Inc. 1.44 2.79 5.49 4.11 4.44
Biogen Inc. 1.72 2.32 2.34 2.55 2.60
Eli Lilly & Co. 1.16 1.73 1.32 1.37 1.53
Gilead Sciences Inc. 3.10 3.38 2.74 2.22 2.50
Illumina Inc. 6.69 2.49 3.99 3.29 3.43
Johnson & Johnson 1.26 1.47 1.41 2.47 2.17
Merck & Co. Inc. 1.24 1.17 1.33 1.78 1.55
Pfizer Inc. 0.88 1.57 1.35 1.25 1.49
Regeneron Pharmaceuticals Inc. 3.67 4.47 3.82 2.56 3.59
Vertex Pharmaceuticals Inc. 3.61 3.43 3.28 2.31 2.78
Zoetis Inc. 2.63 3.60 3.85 3.03 2.15
Current Ratio, Sector
Pharmaceuticals & Biotechnology 1.58 1.74 1.83 2.11 1.94
Current Ratio, Industry
Health Care 1.49 1.53 1.62 1.76 1.72

Based on: 10-K (filing date: 2020-02-24), 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12).

1 2019 Calculation
Current ratio = Current assets ÷ Current liabilities
= 29,354 ÷ 18,304 = 1.60

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Bristol-Myers Squibb Co.’s current ratio improved from 2017 to 2018 but then slightly deteriorated from 2018 to 2019.

Quick Ratio

Bristol-Myers Squibb Co., quick ratio calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Selected Financial Data (US$ in millions)
Cash and cash equivalents 12,346  6,911  5,421  4,237  2,385 
Marketable debt securities 3,047  1,973  1,391  2,113  1,885 
Net trade receivables 6,476  4,636  4,347  3,774  2,948 
Alliance, royalties, VAT and other 1,209  1,111  1,262  1,142  1,169 
Total quick assets 23,078  14,631  12,421  11,266  8,387 
 
Current liabilities 18,304  10,654  9,563  8,841  8,017 
Liquidity Ratio
Quick ratio1 1.26 1.37 1.30 1.27 1.05
Benchmarks
Quick Ratio, Competitors2
Abbott Laboratories 0.88 1.03 1.67 3.31 1.04
AbbVie Inc. 2.91 0.78 0.89 1.14 1.21
Amgen Inc. 1.01 2.44 4.98 3.68 3.97
Biogen Inc. 1.43 1.83 1.78 1.94 1.93
Eli Lilly & Co. 0.68 1.20 0.91 0.98 1.04
Gilead Sciences Inc. 2.86 3.15 2.52 1.78 2.07
Illumina Inc. 6.00 2.23 3.43 2.75 2.90
Johnson & Johnson 0.94 1.08 1.04 2.04 1.77
Merck & Co. Inc. 0.78 0.72 0.83 1.24 1.04
Pfizer Inc. 0.50 0.84 0.93 0.84 1.07
Regeneron Pharmaceuticals Inc. 2.81 3.50 2.98 2.13 3.10
Vertex Pharmaceuticals Inc. 3.33 3.19 2.94 2.06 2.41
Zoetis Inc. 1.67 2.24 2.34 1.47 1.17
Quick Ratio, Sector
Pharmaceuticals & Biotechnology 1.19 1.29 1.41 1.65 1.51
Quick Ratio, Industry
Health Care 1.13 1.12 1.24 1.36 1.32

Based on: 10-K (filing date: 2020-02-24), 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12).

1 2019 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= 23,078 ÷ 18,304 = 1.26

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Bristol-Myers Squibb Co.’s quick ratio improved from 2017 to 2018 but then deteriorated significantly from 2018 to 2019.

Cash Ratio

Bristol-Myers Squibb Co., cash ratio calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Selected Financial Data (US$ in millions)
Cash and cash equivalents 12,346  6,911  5,421  4,237  2,385 
Marketable debt securities 3,047  1,973  1,391  2,113  1,885 
Total cash assets 15,393  8,884  6,812  6,350  4,270 
 
Current liabilities 18,304  10,654  9,563  8,841  8,017 
Liquidity Ratio
Cash ratio1 0.84 0.83 0.71 0.72 0.53
Benchmarks
Cash Ratio, Competitors2
Abbott Laboratories 0.38 0.45 1.08 2.82 0.67
AbbVie Inc. 2.56 0.47 0.59 0.66 0.77
Amgen Inc. 0.69 2.17 4.62 3.40 3.62
Biogen Inc. 0.92 1.07 1.10 1.43 1.33
Eli Lilly & Co. 0.21 0.68 0.55 0.55 0.54
Gilead Sciences Inc. 2.50 2.84 2.19 1.29 1.48
Illumina Inc. 5.13 1.95 2.88 2.21 2.27
Johnson & Johnson 0.54 0.63 0.60 1.59 1.38
Merck & Co. Inc. 0.47 0.40 0.46 0.83 0.70
Pfizer Inc. 0.26 0.59 0.66 0.57 0.79
Regeneron Pharmaceuticals Inc. 1.53 1.95 1.24 0.84 1.29
Vertex Pharmaceuticals Inc. 2.85 2.83 2.59 1.81 2.06
Zoetis Inc. 1.07 1.39 1.43 0.65 0.65
Cash Ratio, Sector
Pharmaceuticals & Biotechnology 0.82 0.90 1.01 1.24 1.11
Cash Ratio, Industry
Health Care 0.73 0.72 0.85 0.95 0.92

Based on: 10-K (filing date: 2020-02-24), 10-K (filing date: 2019-02-25), 10-K (filing date: 2018-02-13), 10-K (filing date: 2017-02-21), 10-K (filing date: 2016-02-12).

1 2019 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= 15,393 ÷ 18,304 = 0.84

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Bristol-Myers Squibb Co.’s cash ratio improved from 2017 to 2018 and from 2018 to 2019.